Diagnos Inc. announced the signing of an agreement with Novartis Pharma AG, for the continuation and expansion of joint deployment and usage of CARA in the United Arab Emirates. Novartis' team in the United Arab Emirates view CARA screening platform as an excellent tool within the context of their activities. With Diagnos Inc.'s assistance, they hope to slow or reverse vision impairment caused by a high prevalence of diabetes within a large patient population.